Last reviewed · How we verify

NCT07317284

Evaluation and Treatment for Diabetic Peripheral Neuropathy

Completed NA Last updated 13 January 2026
What this trial tests

NA trial testing Active Comparator in Diabetic Neuropathy Peripheral in 60 participants. Completed in 20 May 2025.

Timeline
10 July 2024
Primary endpoint
7 April 2025
20 May 2025

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment60
Start date10 July 2024
Primary completion7 April 2025
Estimated completion20 May 2025
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

Adults 45 to 70, any sex, with Diabetic Neuropathy Peripheral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims: * To compare conventional diabetic neuropathy screening techniques with user-friendly technological equipment; * To evaluate the effects of the combined application of laser and therapeutic ultrasound in the treatment of Diabetic Peripheral Neuropathy (DPN) in its early stages, aiming to prevent severe complications, such as the development of diabetic foot. Two groups were formed: Treatment group and placebo group. 24 sessions were performed (twice a week, on alternate days). It is concluded that the combined treatment with laser and therapeutic ultrasound for diabetic peripheral neuropathy promotes a significant reduction in symptoms and improvement in sensitivity in patients with diabetic peripheral neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Active Comparator

Trials testing the same drug.

Other recruiting trials for Diabetic Neuropathy Peripheral

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07317284.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing